Medical Properties Trust Inc.

▲ Bull Case

• ◆Steward transition demonstrably on track — 75% of contracted rents collected as of March 2026; five new regionally dominant operators (Honor Health, Insight, Quorum, HSA, one additional) are materially better credits than Steward; October 2026 100% ramp target is high-confidence and adds ~$0.06/share NFFO with strong visibility.
• ◆International portfolio is an underappreciated stability anchor — UK (Ramsay, Spire; record NHS waiting lists) and Germany (MEDIAN Kliniken; +20% EBITDARM 2025; 90% occupancy) generate stable, growing rents; at an 8% cap rate the ~$3.5–4B international asset base approximates MPW's entire ~$3.6B market cap, effectively pricing the US recovery option near zero.
• ◆Bull case NFFO doubles to ~$1.20/share (20% probability) as Steward completes and Prospect resolves favorably; $3B+ in hospital real estate sold at or above book value during the crisis confirms asset values are real; Q1 2026 first positive GAAP net income since distress began, dividend raised December 2025, and $150M buyback authorized all signal management confidence in the recovery trajectory.

▼ Bear Case

• ◆No competitive moat — ever: two successive catastrophic underwriting failures from separate management decisions reveal a structural weakness in the hospital REIT model, not bad luck; MPW earns ROIC below WACC even in full recovery; it is a carry trade that periodically goes catastrophically wrong, not a compounder.
• ◆Prospect Medical is a 25–40% probability >$500M write-off: California hospital license transfers take 12–24 months; Rhode Island and Texas have separate regulatory processes; MPW cannot control the Chapter 11 plan timetable; a >$700M write-off endangers the 2027 refinancing wall and materially raises the probability of equity dilution.
• ◆2027 refinancing wall is the next existential risk: $1.6B in 2027 maturities requires simultaneous NFFO recovery, favorable credit markets, and continued asset sales at acceptable prices; if Prospect is severe, the refinancing wall becomes a crisis; CEO/Chairman governance is structurally weak with 58.3% say-on-pay approval and no insider buying at $5–6.

“The central Wall Street debate is whether MPW's distress is a transitory tenant-specific problem (two idiosyncratic bankruptcies now being resolved, international portfolio stable, assets selling at book) or a structural model failure (hospital REIT underwriting is inherently broken, leverage >16x NFFO is permanently impaired, a third tenant default would confirm the model is unfixable). Bulls argue the international portfolio alone justifies the market cap and the Steward transition proves management can execute; bears argue the CEO/Chairman governance failure, absence of insider buying, minimal dividend buffer versus peers (OHI, SBRA), and Prospect binary risk make this uninvestable until resolution. The Prospect Medical Chapter 11 outcome — specifically the total write-off amount and rent recovery rate — is the single variable that resolves this debate. Conference call transcripts are unavailable, leaving Prospect state-by-state progress, new operator EBITDARM coverage, and October 2026 refinancing term sheet status as critical blind spots.”

• ◆Prospect Medical Chapter 11 plan filed with total write-off below $300M (primary thesis determinant; expected Q3 2026–Q1 2027)
• ◆Steward rent ramp reaches 100% of contracted ($160M annualized) by October 2026
• ◆€500M October 2026 maturity successfully refinanced (confirms near-term liquidity path)
• ◆NFFO reaches $0.17–0.20+/quarter for two consecutive quarters (recovery momentum confirmed)
• ◆Additional hospital asset sales completed at or above book value (confirms property value floor)
• ◆New independent board members appointed or governance reform announced (reduces structural governance discount)

• ◆Prospect Medical write-off confirmed above $700M — triggers full exit (Kill Switch #1)
• ◆New major tenant (non-Steward/non-Prospect, >5% ABR) files Chapter 11 or announces rent deferral — triggers 60% reduction (Kill Switch #2)
• ◆€500M October 2026 maturity not refinanced by November 30, 2026 — triggers immediate exit (Kill Switch #3)
• ◆Steward rent ramp falls below 60% for two consecutive quarters after October 2026 target — triggers 40% reduction (Kill Switch #4)
• ◆NFFO/share declines QoQ for two consecutive quarters after achieving $0.17+ milestone — triggers 30% reduction (Kill Switch #5)
• ◆2027 refinancing wall ($1.6B) becomes distressed if Prospect severe + credit markets tighten simultaneously
• ◆CEO/Chairman governance failure leads to value-destructive capital allocation (additional hospital acquisitions at inflated prices)